Icecure Medical Stock Performance
| ICCM Stock | USD 1.24 0.06 5.08% |
Icecure Medical holds a performance score of 17 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -0.99, which attests to possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Icecure Medical are expected to decrease slowly. On the other hand, during market turmoil, Icecure Medical is expected to outperform it slightly. Use Icecure Medical downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to analyze future returns on Icecure Medical.
Risk-Adjusted Performance
17 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Icecure Medical are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental indicators, Icecure Medical displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:8 | Last Split Date 2021-08-09 |
1 | Doximity Tops Q2 Earnings and Revenue Estimates | 11/07/2024 |
2 | Surgery Partners Misses Q3 Earnings Estimates | 11/12/2024 |
3 | IceCures ProSense Selected for Major European Breast Cancer Treatment Study ICCM Stock News - StockTitan | 11/19/2024 |
4 | IceCure Medical GAAP EPS of 0.22 , revenue of 2.41M | 11/26/2024 |
5 | IceCure Medical Ltd Q3 2024 Earnings Call Transcript | 11/27/2024 |
6 | H.C. Wainwright reiterates Buy on IceCure Medical stock, FDA decision on ProSense expected soon | 11/29/2024 |
7 | IceCure Medical Stock Price Down 0.4 percent - Heres Why - MarketBeat | 12/20/2024 |
8 | European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology | 01/03/2025 |
9 | The five-year returns have been enviable for IceCure Medical shareholders despite underlying losses increasing | 01/08/2025 |
10 | IceCure Medical CEO Issues Letter to Shareholders Reports Increase of 42 percent in ProSense Sales for 2024 in North America | 01/13/2025 |
| Begin Period Cash Flow | 23.7 M |
Icecure |
Icecure Medical Relative Risk vs. Return Landscape
If you would invest 62.00 in Icecure Medical on October 25, 2024 and sell it today you would earn a total of 62.00 from holding Icecure Medical or generate 100.0% return on investment over 90 days. Icecure Medical is currently generating 1.3367% in daily expected returns and assumes 6.0596% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than Icecure, and 74% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Icecure Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Icecure Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Icecure Medical, and traders can use it to determine the average amount a Icecure Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2206
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ICCM | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.06 actual daily | 54 54% of assets are less volatile |
Expected Return
| 1.34 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Icecure Medical is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Icecure Medical by adding it to a well-diversified portfolio.
Icecure Medical Fundamentals Growth
Icecure Stock prices reflect investors' perceptions of the future prospects and financial health of Icecure Medical, and Icecure Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Icecure Stock performance.
| Return On Equity | -0.94 | ||||
| Return On Asset | -0.47 | ||||
| Operating Margin | (3.19) % | ||||
| Current Valuation | 56.57 M | ||||
| Shares Outstanding | 56.57 M | ||||
| Price To Book | 6.64 X | ||||
| Price To Sales | 20.01 X | ||||
| Revenue | 3.23 M | ||||
| Gross Profit | 1.34 M | ||||
| EBITDA | (15.25 M) | ||||
| Net Income | (14.65 M) | ||||
| Cash And Equivalents | 17.73 M | ||||
| Cash Per Share | 0.48 X | ||||
| Total Debt | 599 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 4.99 X | ||||
| Book Value Per Share | 0.27 X | ||||
| Cash Flow From Operations | (12.52 M) | ||||
| Earnings Per Share | (0.28) X | ||||
| Market Capitalization | 66.75 M | ||||
| Total Asset | 16.41 M | ||||
| Retained Earnings | (90.06 M) | ||||
| Working Capital | 10.31 M | ||||
About Icecure Medical Performance
By examining Icecure Medical's fundamental ratios, stakeholders can obtain critical insights into Icecure Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Icecure Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 387.42 | 259.86 | |
| Return On Tangible Assets | (0.80) | (0.84) | |
| Return On Capital Employed | (1.12) | (1.17) | |
| Return On Assets | (0.80) | (0.84) | |
| Return On Equity | (1.39) | (1.32) |
Things to note about Icecure Medical performance evaluation
Checking the ongoing alerts about Icecure Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Icecure Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Icecure Medical is way too risky over 90 days horizon | |
| Icecure Medical may become a speculative penny stock | |
| Icecure Medical appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 3.23 M. Net Loss for the year was (14.65 M) with profit before overhead, payroll, taxes, and interest of 1.34 M. | |
| Icecure Medical currently holds about 17.73 M in cash with (12.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
| Icecure Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 54.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: IceCure Medical CEO Issues Letter to Shareholders Reports Increase of 42 percent in ProSense Sales for 2024 in North America |
- Analyzing Icecure Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Icecure Medical's stock is overvalued or undervalued compared to its peers.
- Examining Icecure Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Icecure Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Icecure Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Icecure Medical's stock. These opinions can provide insight into Icecure Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share | Quarterly Revenue Growth 0.079 | Return On Assets | Return On Equity |
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.